XJPX7743
Market cap95mUSD
Jan 22, Last price
495.00JPY
1D
0.61%
1Q
1.23%
Jan 2017
-25.75%
Name
Seed Co Ltd
Chart & Performance
Profile
SEED Co.,Ltd. manufactures and supplies contact lenses, care products, spectacle frames, and other eye care products in Japan and internationally. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; SEED MonthlyFine UV and monthly color lens UV replacement contact lenses; rigid gas permeable contact lenses; and medical contact lenses. In addition, the company offers glass frames under the Vivid Moon, ViVi fleurs, and Plusmix brand names; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products for better vision. SEED Co., Ltd. was founded in 1957 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 32,396,752 5.89% | 30,593,819 6.10% | 28,835,337 0.76% | |||||||
Cost of revenue | 30,346,226 | 31,884,413 | 28,991,696 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 2,050,526 | (1,290,594) | (156,359) | |||||||
NOPBT Margin | 6.33% | |||||||||
Operating Taxes | 117,659 | 294,954 | 255,106 | |||||||
Tax Rate | 5.74% | |||||||||
NOPAT | 1,932,867 | (1,585,548) | (411,465) | |||||||
Net income | 1,964,300 -721.44% | (316,089) -127.39% | 1,153,879 2.14% | |||||||
Dividends | (300,336) | (300,440) | (300,220) | |||||||
Dividend yield | 1.78% | 2.20% | 2.30% | |||||||
Proceeds from repurchase of equity | 3,360,773 | 646,998 | (23) | |||||||
BB yield | -19.97% | -4.73% | 0.00% | |||||||
Debt | ||||||||||
Debt current | 15,029,319 | 13,715,594 | 12,631,839 | |||||||
Long-term debt | 15,066,611 | 10,498,044 | 13,265,069 | |||||||
Deferred revenue | 3,130,619 | 3,316,614 | ||||||||
Other long-term liabilities | 3,078,376 | 123,425 | 5,504 | |||||||
Net debt | 19,384,197 | 18,218,918 | 20,944,985 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 6,023,058 | 3,346,559 | 3,266,301 | |||||||
CAPEX | (3,831,999) | (559,566) | (1,116,837) | |||||||
Cash from investing activities | (3,763,711) | (440,734) | (881,609) | |||||||
Cash from financing activities | 2,644,047 | (1,818,963) | (2,423,000) | |||||||
FCF | (2,206,361) | 241,225 | (259,804) | |||||||
Balance | ||||||||||
Cash | 9,889,518 | 4,938,720 | 3,877,923 | |||||||
Long term investments | 822,215 | 1,056,000 | 1,074,000 | |||||||
Excess cash | 9,091,895 | 4,465,029 | 3,510,156 | |||||||
Stockholders' equity | 12,875,850 | 9,041,775 | 9,428,314 | |||||||
Invested Capital | 35,941,267 | 31,557,338 | 33,979,118 | |||||||
ROIC | 5.73% | |||||||||
ROCE | 4.55% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 25,378 | 25,033 | 25,033 | |||||||
Price | 663.00 21.43% | 546.00 4.80% | 521.00 -34.05% | |||||||
Market cap | 16,825,833 23.10% | 13,668,231 4.80% | 13,042,398 -34.05% | |||||||
EV | 36,503,303 | 32,171,099 | 34,262,391 | |||||||
EBITDA | 4,880,933 | 1,413,466 | 2,672,786 | |||||||
EV/EBITDA | 7.48 | 22.76 | 12.82 | |||||||
Interest | 213,379 | 179,892 | 172,315 | |||||||
Interest/NOPBT | 10.41% |